Tune in to see Application Scientists from Nanome discuss how drug design and discovery can be improved across teams using XR. From pocket characterization to docking, and more, teams from all over the world can still come together in the space through the power of XR tools
Keita Funakawa
COO
Nanome
Keita Funakawa is Nanome's COO. Keita’s passion lies at the intersection of emerging technologies, digital arts, and science. He graduated from UC San Diego with a B.S. in Management Science (Quantitative Economics) and a minor in Visual Arts Digital Media. He co-founded Nanome in 2015 and now leads company operations.
Mike Bishop
Drug Discovery Consultant
Nanome
Mike Bishop started Bishop Drug Discovery Consulting in 2019 after 26 years as a medicinal chemist with GSK. From 2001 to 2014 he directed a department of medicinal chemists and DMPK scientists with a focus on metabolic diseases, identifying ~10 clinical development candidates. From 2014 to 2019, Mike served as a Director in GSK’s Discovery Partnerships with Academia (DPAc) unit, with responsibilities for thorough vetting of research opportunities across multiple therapeutic areas, building collaborative workplans and leading joint research programs with academic investigators. Mike earned a B.A. in chemistry from Rice University in Houston, TX, worked in the petrochemical industry with Amoco Chemical in Texas City, TX for two years, and then returned to Rice, earning a Ph.D. in organic chemistry under the guidance of Dr. Marco Ciufolini.
Jonathon Gast
Senior Application Scientist
Nanome
Jonathon Gast has a background in pharmacology, informatics, and medicinal chemistry. He completed his Ph.D. in molecular pharmacology at Purdue University with a focus on the creation of informatic approaches for the determination of mechanisms of action of synthetic lethal combinations. As an applications scientist at Nanome, he communicates with customers to understand their research objectives to create novel solutions through Nanome. This includes the creation of customized software, on-site training, or online demonstrations.
Tune in to see Application Scientists from Nanome discuss how drug design and discovery can be improved across teams using XR. From pocket characterization to docking, and more, teams from all over the world can still come together in the space through the power of XR tools
Keita Funakawa
COO
Nanome
Keita Funakawa is Nanome's COO. Keita’s passion lies at the intersection of emerging technologies, digital arts, and science. He graduated from UC San Diego with a B.S. in Management Science (Quantitative Economics) and a minor in Visual Arts Digital Media. He co-founded Nanome in 2015 and now leads company operations.
Mike Bishop
Drug Discovery Consultant
Nanome
Mike Bishop started Bishop Drug Discovery Consulting in 2019 after 26 years as a medicinal chemist with GSK. From 2001 to 2014 he directed a department of medicinal chemists and DMPK scientists with a focus on metabolic diseases, identifying ~10 clinical development candidates. From 2014 to 2019, Mike served as a Director in GSK’s Discovery Partnerships with Academia (DPAc) unit, with responsibilities for thorough vetting of research opportunities across multiple therapeutic areas, building collaborative workplans and leading joint research programs with academic investigators. Mike earned a B.A. in chemistry from Rice University in Houston, TX, worked in the petrochemical industry with Amoco Chemical in Texas City, TX for two years, and then returned to Rice, earning a Ph.D. in organic chemistry under the guidance of Dr. Marco Ciufolini.
Jonathon Gast
Senior Application Scientist
Nanome
Jonathon Gast has a background in pharmacology, informatics, and medicinal chemistry. He completed his Ph.D. in molecular pharmacology at Purdue University with a focus on the creation of informatic approaches for the determination of mechanisms of action of synthetic lethal combinations. As an applications scientist at Nanome, he communicates with customers to understand their research objectives to create novel solutions through Nanome. This includes the creation of customized software, on-site training, or online demonstrations.